Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Ron Luhmann who wrote (7323)	11/1/1997 12:42:00 PM
From: Kevin Ameling	Read Replies (3) \| Respond to of 14328

Ron and all, a good stock can be held down only so long. We've got 3 qtrs of revenue and earnings growth, a smooth aquisition of new subsidiaries, a diversified product line across three testing catagories, the UNI-Gold approval in the wings to spur more growth in the Point-of-care market...etc. With all this we could now start to look forward to the future valuation of TRIBY. I look at it this way KITS is a similar stock with a P/E of 29. If TRIBY's eps target is 0.15 next year then 29*.15= 4.35 Of course, this assumes a lot, but I think TRIBY is undervalued due to lack of exposure not lack of fundamentals. I hope the new PR firm and the road shows solve this problem and away we go.... All in my opinion, Kevin